Hello. Sign in to personalize your visit. New user? Register now.  
DNA Vaccines 2008
Human Gene Therapy
A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland

To cite this paper:
Elizabeth M. Jaffee, Ross Abrams, John Cameron, Ross Donehower, Mary Duerr, Jeanette Gossett, Tim F. Greten, Louise Grochow, Ralph Hruban, Scott Kern, Keith D. Lillemoe, Seamus O'Reilly, Drew Pardoll, Henry A. Pitt, Patricia Sauter, Christine Weber, Charles Yeo. Human Gene Therapy. September 1, 1998, 9(13): 1951-1971. doi:10.1089/hum.1998.9.13-1951.

Full Text PDF: • HiRes for printing (1,967.5 KB) • PDF Plus w/ links (1,999.2 KB)


Principal Investigator Elizabeth M. Jaffee, M.D.
Department of Oncology, Johns Hopkins University School of Medicine, Ross Building, Room 350, 720 Rutland Avenue, Baltimore, MD 21205, Telephone: 410-955-2957, FAX: 410-614-8216. E-mail: ejaffee@welchlink.welch.jhu.edu
Co-Investigators Ross Abrams, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
John Cameron, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Ross Donehower, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Mary Duerr
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Jeanette Gossett, B.S.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Tim F. Greten, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Louise Grochow, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Ralph Hruban, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Scott Kern, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Keith D. Lillemoe, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Seamus O'Reilly, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Drew Pardoll, M.D., Ph.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Henry A. Pitt, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Patricia Sauter, R.N.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Christine Weber, R.N.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Charles Yeo, M.D.
The Johns Hopkins Oncology Center, 600 N. Wolfe Street, Baltimore, Maryland 21287-7509
Free first page

This paper was cited by:

A Phase I Vaccine Safety and Chemotherapy Dose-Finding Trial of an Allogeneic GM-CSF–Secreting Breast Cancer Vaccine Given in a Specifically Timed Sequence with Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Human Gene Therapy. Mar 2004, Vol. 15, No. 3: 313-337
Citation | Full Text PDF
CCL3/MIP-1α Is a Potent Immunostimulator When Coexpressed with Interleukin-2 or Granulocyte-Macrophage Colony-Stimulating Factor in a Leukemia/Lymphoma Vaccine
Andree Zibert, Stefan Balzer, Manfred Souquet, Trong Hung Quang, Cristina Paris-Scholz, Marie Roskrow, Dagmar Dilloo
Human Gene Therapy. Jan 2004, Vol. 15, No. 1: 21-34
Abstract | Full Text PDF | Reprints & Permissions
Immunization by Particle-Mediated Transfer of the Granulocyte-Macrophage Colony-Stimulating Factor Gene into Autologous Tumor Cells in Melanoma or Sarcoma Patients: Report of a Phase I/IB Study
D.M. Mahvi, F.-S. Shi, N.-S. Yang, S. Weber, J. Hank, M. Albertini, J. Schiller, H. Schalch, M. Larson, L. Pharo, J. Gan, D. Heisey, T. Warner, P.M. Sondel
Human Gene Therapy. Sep 2002, Vol. 13, No. 14: 1711-1721
Abstract | Full Text PDF | Reprints & Permissions
Combination of CD80 and Granulocyte-Macrophage Colony-Stimulating Factor Coexpression by a Leukemia Cell Vaccine: Preclinical Studies in a Murine Model Recapitulating Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
R. Stripecke, D.C. Skelton, P.K. Pattengale, H. Shimada, D.B. Kohn
Human Gene Therapy. Sep 1999, Vol. 10, No. 13: 2109-2122
Abstract | Full Text PDF | Reprints & Permissions
All papers
Previous Next